Comparison of Cytokine,biochemistry and Hepatic Fibrosis Indexes of HBeAg Negative Chronic Hepatitis B
MU Yi-ying,ZHANG Xu,DING Xiang-chun,LI Yu-fang,LIU Ya
DOI: https://doi.org/10.3969/j.issn.1004-583x.2008.05.006
2008-01-01
Abstract:Objective To compare the levels of cytokines interleukin-12(IL-12),interleukin-10(IL-10),interferon-γ(IFN-γ),and degree of liver function,virus load and hepatic fibrosis between HBeAg negative and positive chronic hepatitis B(CHB) patients in the serum,investigate the role of cytokines in HBeAg negative and positive CHB,summarize the feature of HBeAg negative CHB.Methods To measure alanine aminotransferase(ALT),aspartate aminotransferase(AST),total bilirubin(TBil),hepatitis B virus deoxyribonucleic acid(HBV DNA)load,hyaluronic acid(HA),precollagen-Ⅲ(PC-Ⅲ),collagen-Ⅳ(C-Ⅳ),laminin(LN),plasmozyme activity(PTA)of 33 HBeAg negative and 41 HBeAg positive CHB patients,and detect levels of IL-12,IL-10,IFN-γ.Results The course of HBeAg negative CHB patients was longer than that of HBeAg positive CHB patients(6.8±6.2) years vs(3.8±4.0) years(P0.05).Liver function and PTA were not difference in mild,moderate and severe group(P0.05).HBeAg negative CHB HBV DNA load was lower than HBeAg positive CHB(5.1±1.4) vs(6.2±1.5)(P0.05).IL-12 and IFN-γ were higher than those of HBeAg positive CHB(71.3±32.0) ng/L vs(57.7±23.1) ng/L,(16.1±4.8) ng/L vs(13.4±3.3) ng/L(P0.05),but IL-10 showed no significance(P0.05).Hepatic fibrosis index LN of HBeAg negative CHB was more severe than that of HBeAg positive CHB(123.6±61.3) μg/L vs(91.6±45.6) μg/L(P0.05).Conclusion The course of HBeAg negative CHB is longer than that of HBeAg positive CHB.Liver function damage has no difference between HBeAg negative and positive CHB in mild,moderate and severe group.HBV DNA load in HBeAg negative CHB is lower than that of HBeAg positive CHB,IL-12 and IFN-γ play an important role in HBeAg negative CHB.Hepatic fibrosis indexes of HBeAg negative CHB are more severe than those of HBeAg positive CHB,the results suggest that HBeAg negative CHB easily progresses to hepatic cirrhosis.
What problem does this paper attempt to address?